Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark
Testing patients months after their disease can uncover “tiny, subclinical changes,” German data show.
Related Articles
How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy
Experts at ISET hashed out the details, shared new data on bypass vs endo, and tried to make sense of it all as CLTI care…
Poor Sleep Quality Linked to CVD Events and Mortality
Low delta entropy on EEG was able to better predict outcomes than traditional overnight polysomnography measures.
Public Comment Period Opens for New CV Medicine Board
For the next 3 months, individuals can weigh in on the effort to move certification of cardiologists away from the ABIM.
Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details
A deep dive into a French study shows the benefit was seen in older, sicker patients who were at high risk for surgery.
Medical Imaging Has a Climate Problem: Radiologists Outline a Plan
Coinciding with Earth Day, a new paper tackles how imagers can improve sustainability, while preparing for environmental crises.
BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI
Prominent trialists took issue with the primary endpoint, how it was powered, and what effect COVID-19 and Katsanos played.
TCTMD’s Quick Takes: Dr. Julia Colombijn
Julia Colombijn, MSc, highlights the systematic underrepresentation of CKD patients in cardiovascular clinical trials.
Short Bouts of Physical Activity May Offset Occupational Sitting CVD Risks
Frequent bathroom breaks and setting timers to remind you to stand up can nudge people in the right direction, says Carl Lavie.
Pregnancy Complications Impart Higher Death Risk for Decades
Adverse pregnancy outcomes, though often overlooked by busy clinicians, should spur early prevention and close attention.
April 2024: Key Takeaways From ACC 2024
Hear some hot takes on REDUCE-AMI, ORBITA-COSMIC, PREVENT, and more of the top news this month.